CME Group

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade CME Group 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CME

CME Group, Inc. operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals. 

CEO
Terrence A. Duffy
CEOTerrence A. Duffy
Employees
3,875
Employees3,875
Headquarters
Chicago, Illinois
HeadquartersChicago, Illinois
Founded
1898
Founded1898
Employees
3,875
Employees3,875

CME Key Statistics

Market cap
89.42B
Market cap89.42B
Price-Earnings ratio
20.79
Price-Earnings ratio20.79
Dividend yield
4.62%
Dividend yield4.62%
Average volume
3.33M
Average volume3.33M
High today
$247.03
High today$247.03
Low today
$243.03
Low today$243.03
Open price
$243.20
Open price$243.20
Volume
246.89K
Volume246.89K
52 Week high
$329.16
52 Week high$329.16
52 Week low
$218.31
52 Week low$218.31

Stock Snapshot

As of today, CME Group(CME) shares are valued at $246.77. The company's market cap stands at 89.42B, with a P/E ratio of 20.79 and a dividend yield of 4.62%.

During the trading session on 2026-07-15, CME Group(CME) shares reached a daily high of $247.03 and a low of $243.03. At a current price of $246.77, the stock is +1.5% higher than the low and still -0.1% under the high.

Trading activity shows a volume of 246.89K, compared to an average daily volume of 3.33M.

Over the past 52 weeks, CME Group(CME) stock has traded between a high of $329.16 and a low of $218.31.

Over the past 52 weeks, CME Group(CME) stock has traded between a high of $329.16 and a low of $218.31.

CME News

TipRanks 4h
CME Group price target lowered to $295 from $329 at Piper Sandler

Piper Sandler lowered the firm’s price target on CME Group (CME) to $295 from $329 and keeps an Overweight rating on the shares. The firm updated models in the...

MarketWatch 2d
CME Group Inc. Cl A stock outperforms competitors on strong trading day - MarketWatch

...

CME Group Inc. Cl A stock outperforms competitors on strong trading day - MarketWatch
Simply Wall St 3d
CME Group Expands Its Product Suite, Is The Stock Cheap?

CME Group (CME) has just outlined a cluster of new products, led by the planned Treasury Link platform that connects U.S. Treasury futures and cash markets and...

CME Group Expands Its Product Suite, Is The Stock Cheap?

Analyst ratings

55%

of 20 ratings
Buy
55%
Hold
30%
Sell
15%

More CME News

Simply Wall St 6d
Is CME Group’s Futures Innovation Spree Quietly Redefining Its Core Risk-Management Moat?

CME Group has recently unveiled a wave of product innovations, including Treasury Link to connect U.S. Treasury futures and cash markets, a new Agriculture Inde...

Is CME Group’s Futures Innovation Spree Quietly Redefining Its Core Risk-Management Moat?
TipRanks 6d
CME Group price target lowered to $270 from $316 at Barclays

Barclays lowered the firm’s price target on CME Group (CME) to $270 from $316 and keeps an Equal Weight rating on the shares. Unlock powerful investing tools a...

People also own

Based on the portfolios of people who own CME. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.